Weinberg DS - Search Results

1

Colorectal Cancer Screening in the United States: What Is the Best FIT?

Weinberg DS, Barkun A, Turner BJ. Weinberg DS, et al. Ann Intern Med. 2017 Feb 21;166(4):297-298. doi: 10.7326/M16-2341. Epub 2016 Oct 25. Ann Intern Med. 2017. PMID: 27776358 Free PMC article. No abstract available.

2

Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.

Baig N, Myers RE, Turner BJ, Grana J, Rothermel T, Schlackman N, Weinberg DS. Baig N, et al. Among authors: weinberg ds. Am J Gastroenterol. 2003 Sep;98(9):2078-81. doi: 10.1111/j.1572-0241.2003.07575.x. Am J Gastroenterol. 2003. PMID: 14499791

3

A survey of women regarding factors affecting colorectal cancer screening compliance.

Weinberg DS, Turner BJ, Wang H, Myers RE, Miller S. Weinberg DS, et al. Prev Med. 2004 Jun;38(6):669-75. doi: 10.1016/j.ypmed.2004.02.015. Prev Med. 2004. PMID: 15193887

4

Making the case for the benefits of primary care from observational studies: does an ounce of prevention take a pound of doctor visits?

Turner BJ, Weinberg DS. Turner BJ, et al. Among authors: weinberg ds. Ann Intern Med. 2013 Oct 1;159(7):494-5. doi: 10.7326/0003-4819-159-7-201310010-00011. Ann Intern Med. 2013. PMID: 24081289 No abstract available.

5

Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.

Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N. Turner B, et al. J Gen Intern Med. 2003 May;18(5):357-63. doi: 10.1046/j.1525-1497.2003.20525.x. J Gen Intern Med. 2003. PMID: 12795734 Free PMC article.

6

Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.

Myers RE, Turner B, Weinberg D, Hauck WW, Hyslop T, Brigham T, Rothermel T, Grana J, Schlackman N. Myers RE, et al. Prev Med. 2001 Oct;33(4):249-60. doi: 10.1006/pmed.2001.0878. Prev Med. 2001. PMID: 11570828 Clinical Trial.

7

Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation.

Jimbo M, Myers RE, Meyer B, Hyslop T, Cocroft J, Turner BJ, Weinberg DS. Jimbo M, et al. Among authors: weinberg ds. Ann Fam Med. 2009 Jan-Feb;7(1):11-6. doi: 10.1370/afm.906. Ann Fam Med. 2009. PMID: 19139444 Free PMC article. Clinical Trial.

8

Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer.

Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Hyslop T, et al. Among authors: weinberg ds. Clin Cancer Res. 2011 May 15;17(10):3293-303. doi: 10.1158/1078-0432.CCR-10-3113. Epub 2011 Feb 9. Clin Cancer Res. 2011. PMID: 21307149 Free PMC article.

9

Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes.

Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Hyslop T, et al. Among authors: weinberg ds. Cancer. 2012 May 1;118(9):2532-40. doi: 10.1002/cncr.26516. Epub 2011 Sep 1. Cancer. 2012. PMID: 21887684 Free PMC article.

10

From Colorectal Cancer Screening Guidelines to Headlines: Beware!

Bretthauer M, Kalager M, Weinberg DS. Bretthauer M, et al. Among authors: weinberg ds. Ann Intern Med. 2018 Sep 18;169(6):405-406. doi: 10.7326/M18-1720. Epub 2018 Jul 10. Ann Intern Med. 2018. PMID: 29987330 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters